Distinct EBV-Associated Phenotypes Due to a Novel Homozygous Missense Variant in CD27.
Rui YangiD, Solomon K Turunbedu, Sara Nandiwada, Choladda V. CurryiD, Tarek M. Elghetany, Brooks Scull, Junnan Geng, Alexander Vargas‐HernándeziD, Ivan Kingyue ChinniD, Sebastian OchoaiD, Carl E. AlleniD, Lisa Forbes Satter
Abstract
Biallelic deficiencies of CD27 and its ligand CD70 underlie selective susceptibility to Epstein-Barr virus (EBV) infection and its acute and chronic complications, underscoring their non-redundant roles in anti-EBV immunity. To date, 16 pathogenic CD27 variants have been reported. Here, we describe three patients from two unrelated families, homozygous for a novel loss-of-function (LOF) CD27 variant, resulting in substitution of serine 70 with proline (S70P). All three patients presented with EBV viremia and lymphoproliferative disease, with variable immune dysregulation or recurrent otosinopulmonary infections. One patient developed EBV-associated Hodgkin lymphoma. Functional studies demonstrated that the S70P variant impaired surface expression of CD27 and abolished CD70 binding, rendering complete LOF. Together, S70P represents a novel pathogenic CD27 variant causing autosomal recessive (AR) CD27 deficiency, characterized by a unified susceptibility to EBV yet variable clinical manifestations, ranging from chronic viremia to malignancy.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 23th percentile
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Insights into the Absence of Lymphoma Despite Fulminant Epstein-Barr Virus Infection in Patients with XIAP Deficiency
Yizhe Sun, Janet S. Chou, … Benjamin E. Gewurz·JCI InsightPeer-reviewed·Jul 15, 2025
- Characterization of an immunodeficiency-associated EZH2 variant
Francisco Perez de los Santos, Lily Beck, … Aaron M. Johnson·bioRxiv·Jan 21, 2026
- Two common disease-associated TYK2 variants impact exon splicing and TYK2 dosage
Z. Li, M. Rotival, … S. Pellegrini·bioRxiv·Nov 4, 2019
- EBV INFECTION OUTCOMES DETERMINED BY MONOCYTE AND TREG-DRIVEN IMMUNE DYNAMICS IN AN EX VIVO PBMC MODEL
Leena Yoon, Lauren N. MacMullen, … Paul M. Lieberman·bioRxiv·Nov 20, 2025
- Epstein-Barr Virus Induced Cytidine Metabolism Roles in Transformed B-cell Growth and Survival
J.-H. Liang, C. Wang, … B. Gewurz·bioRxiv·Jan 8, 2021
- EBV reprograms autoreactive B cells as antigen presenting cells in multiple sclerosis
Shady Younis, Sajede Rasouli, … William H. Robinson·bioRxiv·Feb 12, 2026